Cantor Fitzgerald Weighs in on Axsome’s FY2022 Earnings (NASDAQ:AXSM)

 Equities researchers at Cantor Fitzgerald lowered their FY2022 EPS estimates for shares of Axsome Therapeutics in a report issued on Tuesday, May 3rd. Cantor Fitzgerald analyst C. Duncan now expects that the company will earn ($4.13) per share for the year, down from their prior estimate of ($3.69).

https://www.defenseworld.net/2022/05/06/cantor-fitzgerald-weighs-in-on-axsome-therapeutics-inc-s-fy2022-earnings-nasdaqaxsm.html